Combination Immunotherapy in the First-Line Treatment of Advanced RCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Emerging Role of Combination Immunotherapy in the First-Line Treatment of Advanced Renal Cell Carcinoma: A Review
JAMA Oncol 2018 Nov 21;[EPub Ahead of Print], S George, BI Rini, HJ HammersFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.